Scopus Eşleşmesi Bulundu
8
Atıf
50
Cilt
706-719
Sayfa
Özet
Objective: In the current research, 6-gingerol (GA)-loaded nanofiber drug delivery system were developed, and their potential usage in wound healing was evaluated. Significance: This study investigates the effectiveness of nanofibrous membranes composed of sodium alginate (SA), poly(vinyl alcohol) (PVA), and 6-gingerol (GA) as delivery systems for anti-inflammatory agents in the context of wound dressings. Methods: GA-loaded SA/PVA nanofiber was prepared using electrospinning. In vitro characterization of this nanofiber included the examination of comprehensive in vitro characterization, anti-inflammatory and antioxidant activities, cytotoxicity, a scratch tes and in vivo skin test. Results: GA was extracted from Zingiber officinale, and its successful isolation was confirmed through analyses such as H-NMR, C-NMR. Then GA was electrospuned into the SA/PVA nanofibers, and scanning electron microscopy (SEM) imaging revealed that the fiber diameters of the formulations ranged between 148 nm and 176 nm. Anti-inflammatory and antioxidant studies demonstrated that the effectiveness of GA increased with higher doses; however, this increase was accompanied by decreased cell viability. In vitro release studies revealed that GA exhibited a burst release within the first 8 h, followed by a controlled release, reaching completion within 24 h. Within the scope of in vitro release kinetics, release data are mathematically compatible with the Weibull model with high correlation. The scratch test results indicated that TB2 (%1 GA) promoted epithelialization. Furthermore, it was determined that TB2 (%1 GA) did not cause any irritation. Conclusions: As a result, TB2 shows promise as a formulation for wound dressings, offering potential benefits in the field of wound care.
Web of Science Eşleşmesi Bulundu
7
WoS Atıf
50
Cilt
Article
Belge Türü
Kaynak: DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY
· s. 706-719
Anahtar Kelimeler (WoS)
Havuzumuzdaki Atıflar 0
Bu makaleye, sistemimizdeki Scopus veritabanında bulunan 0 makale atıf yapmıştır. Scopus genel atıf sayısı: 8.
Bu makaleye, kendi Scopus havuzumuzdaki başka bir makaleden atıf kaydı bulunmuyor.
Scimago Dergi Bilgisi
Otomatik ISSN Eşleştirmesi
2024 yılı verileri
Drug Development and Industrial Pharmacy
Q2
SJR Quartile
0,451
SJR Skoru
106
H-Index
Kategoriler: Pharmaceutical Science (Q2) · Drug Discovery (Q3) · Organic Chemistry (Q3) · Pharmacology (Q3)
Alanlar: Chemistry · Pharmacology, Toxicology and Pharmaceutics
Ülke: United States
· Informa Healthcare
Bu bilgiler makale yılına göre Scimago veritabanından ISSN eşleştirmesiyle otomatik getirilmektedir.
Dergi sıralama verileri Scimago'nun ilgili yılı baz alınmaktadır.
Anahtar Kelimeler
WoS |
Bir kelimeye tıklayıp ilgili kaynaktaki yayınları görün.
Makale Bilgileri
Dergi
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY
ISSN
0363-9045
Yıl
2024
/ 12. ay
Cilt / Sayı
50
/ 7
Sayfalar
706 – 719
Makale Türü
Özgün Makale
Hakemlik
Hakemli
Endeks
SCI-Expanded
JCR Quartile
Q3
Teşvik Puanı
0,90
· YÖKSİS Akademik Teşvik
Yayın Dili
İngilizce
Kapsam
Uluslararası
Toplam Yazar
10 kişi
Erişim Türü
Basılı+Elektronik
Alan
Sağlık Bilimleri Temel Alanı
Farmakoloji
YÖKSİS Yazar Kaydı
Yazar Adı
POLAT HEYBET KEREM,GÖZCÜ SEFA,ÜNAL SEDAT,PAÇACI TİMUR,AYTEKİN EREN,KARAKUYU NASIF FATİH,KÖNGÜL ŞAFAK ESRA,GÜLTEKİN YAKUP,YAZIKSIZ YONCA,KURT NİHAT
YÖKSİS ID
8014604